Jiangsu Apon Medical Technology Co., Ltd.

SZSE:300753 Stock Report

Market Cap: CN¥1.9b

Jiangsu Apon Medical Technology Balance Sheet Health

Financial Health criteria checks 4/6

Jiangsu Apon Medical Technology has a total shareholder equity of CN¥697.5M and total debt of CN¥48.4M, which brings its debt-to-equity ratio to 6.9%. Its total assets and total liabilities are CN¥840.6M and CN¥143.1M respectively. Jiangsu Apon Medical Technology's EBIT is CN¥764.4K making its interest coverage ratio 0.3. It has cash and short-term investments of CN¥159.6M.

Key information

6.9%

Debt to equity ratio

CN¥48.40m

Debt

Interest coverage ratio0.3x
CashCN¥159.59m
EquityCN¥697.46m
Total liabilitiesCN¥143.13m
Total assetsCN¥840.59m

Recent financial health updates

No updates

Recent updates

Jiangsu Apon Medical Technology Co., Ltd.'s (SZSE:300753) Share Price Boosted 39% But Its Business Prospects Need A Lift Too

Oct 09
Jiangsu Apon Medical Technology Co., Ltd.'s (SZSE:300753) Share Price Boosted 39% But Its Business Prospects Need A Lift Too

Insufficient Growth At Jiangsu Apon Medical Technology Co., Ltd. (SZSE:300753) Hampers Share Price

Jul 02
Insufficient Growth At Jiangsu Apon Medical Technology Co., Ltd. (SZSE:300753) Hampers Share Price

Jiangsu Apon Medical Technology Co., Ltd.'s (SZSE:300753) Share Price Boosted 41% But Its Business Prospects Need A Lift Too

Mar 08
Jiangsu Apon Medical Technology Co., Ltd.'s (SZSE:300753) Share Price Boosted 41% But Its Business Prospects Need A Lift Too

Financial Position Analysis

Short Term Liabilities: 300753's short term assets (CN¥434.9M) exceed its short term liabilities (CN¥111.7M).

Long Term Liabilities: 300753's short term assets (CN¥434.9M) exceed its long term liabilities (CN¥31.4M).


Debt to Equity History and Analysis

Debt Level: 300753 has more cash than its total debt.

Reducing Debt: 300753's debt to equity ratio has increased from 0% to 6.9% over the past 5 years.

Debt Coverage: 300753's debt is well covered by operating cash flow (23.8%).

Interest Coverage: 300753's interest payments on its debt are not well covered by EBIT (0.3x coverage).


Balance Sheet


Discover healthy companies